Caprock Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.41M Sell
20,878
-495
-2% -$107K 0.11% 166
2025
Q4
$4.39M Buy
21,373
+6,274
+42% +$1.18M 0.09% 183
2025
Q3
$2.25M Buy
+15,099
New +$2.33M 0.06% 316
2025
Q1
$2.77M Sell
20,099
-797
-4% -$102K 0.08% 208
2024
Q4
$2.47M Sell
20,896
-1,070
-5% -$125K 0.08% 218
2024
Q3
$2.43M Buy
21,966
+57
+0.3% +$5.96K 0.09% 198
2024
Q2
$2.15M Buy
21,909
+19,277
+732% +$1.96M 0.09% 189
2024
Q1
$296K Buy
2,632
+126
+5% +$13.6K 0.02% 565
2023
Q4
$254K Buy
2,506
+45
+2% +$4.46K 0.02% 585
2023
Q3
$214K Buy
2,461
+65
+3% +$5.88K 0.02% 593
2023
Q2
$228K Buy
+2,396
New +$202K 0.02% 580
2021
Q3
Sell
-6,017
Closed -$346K 544
2021
Q2
$346K Buy
+6,017
New +$352K 0.03% 328

Other funds holding CAH

Caprock Group's CAH Position: Q1 2026 in Review

Caprock Group reduced its Cardinal Health (CAH) stake by 2.3% in Q1 2026, selling an estimated $107K and leaving 20,878 shares worth $4.41M. The position accounts for 0.11% of the portfolio, ranked #166.

Caprock Group first reported a position in CAH in Q2 2021 and has held it in 12 quarters since. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Caprock Group held 20,878 shares of Cardinal Health worth $4.41M as of Q1 2026.
  • Caprock Group sold 495 Cardinal Health shares in Q1 2026, an estimated $107K.
  • Cardinal Health made up 0.11% of Caprock Group's portfolio in Q1 2026, its #166 holding.
  • Caprock Group first reported a position in Cardinal Health in Q2 2021 and has held it in 12 quarters since.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.